Evanston Entrepreneurship Support Grant

The Food and Fiber Processing Grant Program, administered by the Farm and Food Growth Fund (FFGF) on behalf of the New York State Department of Agriculture and Markets, supports the scaling of existing and new products produced and harvested in New York State. Funding is available for the construction and renovation of facilities, as well as the purchase and installation of equipment. Priority will be given to projects that expand processing for fruits, vegetables, grains and beans for human consumption; plant and animal fibers. Eligible applicants may apply for awards ranging from $250,000 to $2.5 million. Of the $8.5 million available, $1 million is reserved for projects that use plant and animal fiber. Processed products developed through the grant must contain a minimum of 51% raw agricultural ingredients grown or raised in New York State.

Through this Notice of Funding Opportunity, the National Cancer Institute (NCI) seeks research projects that implement early phase (Phase 0, I, and II) investigator-initiated clinical trials focused on cancer-targeted diagnostic and therapeutic interventions of direct relevance to the research mission of DCTD and OHAM. The proposed project must involve at least 1 clinical trial related to the scientific interests of one or more of the following research programs: Cancer Therapy Evaluation Program, Cancer Imaging Program, Cancer Diagnosis Program, Radiation Research Program, Complementary and Alternative Medicine Program and/or the HIV and AIDS Malignancies Research Programs. Applicants may propose to conduct an early phase trial by itself, or in combination with another research aim(s) as appropriate.

The objective of the Façade Improvement Grant (FIG) program is to restore, sustain, and improve commercial properties located within the City of Newport News. The FIG program provides matching grant funds, up to a maximum of $20,000, to assist with eligible façade improvements on properties citywide that are used for commercial, industrial, office or mixed-use purposes.

This Notice of Funding Opportunity (NOFO) encourages grant applications for Animal and Biological Material Resource Centers. These Centers provide support for special colonies of laboratory animals and associated services, as well as other resources such as informatics tools, reagents, cultures (cells, tissues, and organs) and genetic stocks that serve the biomedical research community in a variety of research areas on a local, regional, and national basis. The goal of projects supported by this NOFO is to provide research resources that facilitate optimization and enhancement of scientific rigor, transparency, and experimental reproducibility of biomedical research. Proposed Animal and Biological Material Resource Centers must have broad application to multiple NIH Institutes or Centers (ICs) to align with the ORIP"s NIH-wide mission (https://orip.nih.gov/about-orip). This funding opportunity is designed to support both continuation of existing resources and to develop new ones when appropriate. Of special interest of the announcement is a requirement of the Center"s close coordination with efforts to develop new approach methodologies (NAMs) that complement traditional animal-based research. These include cell culture, organoids, computational models, and microphysiological systems. Applied Research Component should include studies to generate comparative data to increase applicability of NAMs and promote integration of the most predictive human disease models.

The Rhode Island Lift Program is a strategic investment initiative designed to fuel the growth and successful capital raise of high-impact life sciences companies in Rhode Island. This competitive program provides a non-dilutive funding boost to companies that have finalized or recently closed a funding round. By offering this last infusion of capital, the program helps high-potential life sciences ventures scale their operations, drive innovation, and strengthen their impact on the state’s economy, industry growth, and patient outcomes. Through this support, Rhode Island continues to position itself as a leader in life sciences advancement and commercialization.